What are the clinical features of hypersensitive pneumonitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Features of Hypersensitivity Pneumonitis

Hypersensitivity pneumonitis (HP) is characterized by an immunologically mediated inflammatory response in the lungs following inhalation of environmental or occupational antigens, presenting with distinct clinical, radiological, and histopathological features that vary based on disease stage and chronicity. 1

Clinical Presentation

General Features

  • Dyspnea, cough, and inspiratory crackles are common clinical manifestations across all forms of HP 1
  • Gastroesophageal reflux disease is frequently present in patients with HP 1
  • Inspiratory squawks (squeaky sounds during inspiration) may be present on auscultation 1
  • Weight loss is a significant predictor of HP and is more common in chronic forms 2

Acute HP

  • Fever, chills, malaise, and myalgias occurring 4-8 hours after antigen exposure 2
  • Symptoms resemble influenza-like illness with nonproductive cough and dyspnea 2, 3
  • Symptoms typically resolve within 24-48 hours if exposure is discontinued 4

Subacute/Chronic HP

  • Insidious and chronic onset of isolated pulmonary symptoms 1
  • Progressive dyspnea, fatigue, and weight loss over months 3
  • Symptoms may not clearly correlate with specific exposures 1
  • May progress to respiratory insufficiency and death if exposure continues 5

Radiological Features

High-Resolution CT Findings

  • Nonfibrotic (Acute/Subacute) HP:

    • Centrilobular nodules 1, 4
    • Mosaic attenuation on inspiratory scans 1
    • Air trapping on expiratory scans 1, 4
    • Ground-glass opacities and occasional cysts 1
  • Fibrotic (Chronic) HP:

    • Coarse reticulation with minimal honeycombing in random distribution 1
    • Evidence of small airway disease 1
    • Variable patterns including basal/subpleural predominance, upper-lung-zone predominance, or central (peribronchovascular) predominance 1
    • May mimic usual interstitial pneumonia (UIP) or nonspecific interstitial pneumonia (NSIP) patterns 6

Histopathological Features

Nonfibrotic (Cellular) HP

  • Cellular interstitial pneumonia with bronchiolocentric (airway-centered) distribution 1
  • Lymphocyte-predominant inflammation 1
  • Cellular bronchiolitis with lymphocyte predominance 1
  • Poorly formed non-necrotizing granulomas 1
    • Loose clusters of epithelioid cells and/or multinucleated giant cells 1
    • Located in peribronchiolar interstitium, terminal air spaces, and/or organizing pneumonia 1

Fibrotic HP

  • Chronic fibrosing interstitial pneumonia with architectural distortion 1
  • Airway-centered fibrosis with peribronchiolar metaplasia 1
  • May show fibrotic NSIP-like pattern 1
  • May retain some features of cellular HP in less fibrotic areas 1
  • Bridging fibrosis spanning subpleural and centriacinar regions 1

Laboratory Findings

  • Bronchoalveolar lavage (BAL) typically shows lymphocytosis (especially >30%) 1, 2
  • CD4+/CD8+ ratio <1 in BAL fluid 2
  • Positive precipitating antibodies to the offending antigen may be present 2
  • Pulmonary function tests show restrictive pattern in most cases, but may show obstruction or mixed pattern with avian exposure 2

Diagnostic Approach

The diagnosis of HP relies on three primary domains 1:

  1. Identification of exposure to a causative antigen 1
  2. Characteristic imaging pattern on HRCT 1
  3. BAL lymphocytosis or compatible histopathological findings 1

Common Pitfalls and Caveats

  • HP is frequently misdiagnosed as idiopathic interstitial pneumonia, particularly in chronic forms 1
  • Fibrotic HP can be difficult to distinguish from idiopathic pulmonary fibrosis (IPF) due to overlapping features 1
  • Not all exposed individuals develop the disease, suggesting genetic susceptibility factors 6
  • Absence of an identifiable exposure does not rule out HP (no clear antigen identified in approximately 50% of cases) 1
  • Histopathological findings of HP may overlap with other interstitial lung diseases, requiring multidisciplinary discussion for accurate diagnosis 1
  • Early diagnosis and antigen avoidance are critical for preventing progression to irreversible fibrosis 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hypersensitivity pneumonitis.

Allergy and asthma proceedings, 2019

Research

Hypersensitivity pneumonitis.

Allergy, 2009

Research

Hypersensitivity pneumonitis: insights in diagnosis and pathobiology.

American journal of respiratory and critical care medicine, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.